BETHESDA, MD (UroToday.com) - In his session, Dr. Dean Bajorin from the Germ Cell Group at MSKCC discussed new data in the treatment of seminoma.
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
SUO 2008 - Stage I Seminoma: How Does New Data Affect Treatment Recommendations? - Session Highlights
Your session will expire in 8 hours requiring you to log in each day to view content.